ABSTRACT-The effects of a novel tachykinin NK1-receptor antagonist HSP-117 {(2S,3S)-3-[(5-isopropyl-2,3-dihydrobenzofuran-7-yl)methyl]amino-2-phenylpiperidine dihydrochloride} on cisplatin-induced pica, i.e., the eating of nonnutritive substances such as kaolin were examined in rats. HSP-117 inhibited kaolin intake in a dose-dependent manner for 2 days. The 5-HT 3-receptor antagonist ondansetron inhibited only on the first day, but not on the second day. These results indicate that the cisplatin-induced kaolin intake on the first day is related to both 5-HT3-and NK1 receptors, while only the NK1 receptor is involved on the second day. Thus, cisplatin-induced continuous pica in rats represents a useful model of not only acute but also delayed emesis.
Although rats are commonly used as laboratory animals in many studies, they have not been commonly used for studies on emesis, because rats as well as mice and guinea pigs are not susceptible to vomiting. Takeda et al. (1 -3) reported that pica, i.e., the ingestion of nonnutritive substances such as kaolin, in rats was induced by various emetic stimuli such as copper sulfate, apomorphine, cisplatin, an anticancer drug, and motion. Based on their findings, they concluded that pica in rats is analogous to vomiting in other species and suggested that it may be a useful animal model for research on emesis.
Bountra et al. (4) reported that the tachykinin NK1-receptor antagonist CP-99,994 had anti-emetic activity in ferrets, and this was followed by a number of pharmacological studies demonstrating that selective NK1-receptor antagonists such as CP-122,721 (5), GR203040 (6) or GR205171 (7) exhibited potent anti-emetic properties against a wide variety of emetogens, which act centrally, peripherally or at a mixed site. The anti-emetic activity and effect of these NK1-receptor antagonists were potent and broad. Furthermore, the characteristics of these drugs have been shown to be dependent on penetration into the brain (8, 9) , which are consistent with their acting centrally. Hence, the NK 1 antagonists are represented as a new class of antiemetics (10) .
We previously reported that a novel and selective NK1-receptor antagonist, HSP-117 {(2S,3S)-3-[(5-isopropyl-2,3-dihydrobenzofuran-7-yl)methyl]amino-2-phenylpiperidine dihydrochloride}, inhibited morphine-and copper sulfateinduced emesis in ferrets, suggesting that HSP-117 may act centrally via the nucleus tractus solitarius and/or the area postrema (11, 12) .
However, no reports have mentioned the effects of NK1-receptor antagonists on pica in rats as an analogue to emesis in other species, especially the evaluation of a cisplatininduced delayed emesis, which occurs 24 h or later after cisplatin injection. The use of pica to evaluate the delayed emesis in rats would be useful in further examining the involvement of NK1 receptor in the developmental mechanism of emesis, because rats have been extensively researched morphologically, electrophysiologically and neuroanatomically. In the present study, we have examined the effects of HSP-117 on cisplatin-induced pica in rats.
Male Wistar rats weighing about 150 g (Kyudo Co., Kumamoto) were used. The rats were housed in a room at 20 -23°C with a 12:12-h light-dark cycle (light on at 07:00 h) and were given free access to commercial food (Kyudo Co.) and tap water. A kaolin clod was prepared by the method of Takeda et al. (1) with slight modifications. Kaolin was mixed with 1% gum arabic in adequate distilled water to form golf ball size clods weighing about 50 g, which were dried at room temperature. The glass container of kaolin clods was placed along with that of standard food in the cage for 3 days before the experiment, and the animals were allowed to adapt to the presence of both containers. Each kaolin clod and standard food container was removed, weighed to the nearest 0.1 g refilled, and replaced at 18:00 h each day. Kaolin splinters were collected, dried, and weighed, in order to arrive at a correct value of intake. After a 3-day adaptation period, animals were given cisplatin via an intraperitoneal (i.p.) injection. Each kaolin and standard food intake was then measured at 24-h intervals for a maximum of 7 days. HSP-117, its inactive en-
or intracerebroventricularly (i.c.v.) by a single administration 10 min prior to the cisplatin injection. Ondansetron (2 mg/ kg) and its combination with dexamethasone (1 mg /kg) were given i.p. at 10 min before, 24 and 48 h after the cisplatin injection.
For i.c.v. injection of drugs, a 21-gauge stainless guide cannula (length 13 mm) was inserted into the right lateral brain ventricle (coordination site: anterial, -0.8 mm; lateral, 1.3 mm from the bregma). The tip of the guide cannula was located vertically 3.3 mm below the skull surface and the cannula was fixed to the skull with dental cement and two holding screws. The animals were then allowed to recover for 7 days before experiments.
CP-99,994, HSP-117 and (R)-HSP-117 synthesized at Hisamitsu Pharmaceutical Co., Inc. (Tsukuba). Ondansetron and dexamethasone were purchased from Sankyo (Tokyo). Cisplatin was purchased from Sigma (St. Louis, MO, USA). These compounds were dissolved in saline or artificial cerebrospinal fluid. Kaolin and gum arabic were purchased from Katayama Chemical (Osaka).
Data are expressed as the mean ± S.E.M. of each treatment group. Significant differences between the control and treatment groups were determined by one-way analysis of variance (ANOVA) by Dunnett's test.
To elucidate the characteristics of cisplatin-induced pica in rats, kaolin intake was observed for 7 days after the injection of cisplatin at doses of 5 and 10 mg / kg. The intake on the first day and on the second day after cisplatin (10 mg/ kg) increased significantly during the observation period (Table 1) .
Single i.p. administration of the NK1-receptor antagonists HSP-117 (3 -40 mg / kg) and CP-99,994 (20 -60 mg /kg) inhibited the increase in kaolin intake on the first and the second days in a dose-dependent manner. However, (R)-HSP-117 (40 mg/ kg) was ineffective (Fig. 1A) . Similarly, i.c.v. administration of either HSP-117 (40 -400 mg) or CP-99,994 (0.6 -600 m g) resulted in a dose-dependent inhibition, but that of (R)-HSP-117 (400 mg) had no effect (Fig. 1B) .
The repeated administration of the 5-HT 3-receptor antagonist ondansetron (2 mg/ kg, i.p.) significantly inhibited the increase in kaolin intake only on the first day, but not on subsequent days after the cisplatin injection. However, the co-administration of ondansetron (2 mg / kg, i.p.) and dexamethasone (1 mg/kg, i.p.) significantly inhibited the increase of kaolin intake on the first day, and kaolin intake on the second days was somewhat decreased (Fig. 2) .
Both NK1-receptor antagonists, HSP-117 (3 -40 mg / kg, i.p.) and CP-99,994 (20 -60 mg/kg, i.p.), and the 5-HT3-receptor antagonist ondansetron did not affect the other behaviors of ferrets.
In a previous study, Takeda et al. (1) reported that kaolin intake in rats could be induced by a variety of emetic stimuli, including apomorphine, copper sulfate, cisplatin and motion, and that corresponding antiemetics, such as domperidone, ondansetron and diphenhydramine, led to inhibition, respectively. These results suggest that this may be a useful model of emesis (1 -3) . However, the effects of selective NK1-receptor antagonists on pica in rats has not yet been reported. Therefore, we examined the effects of HSP-117, a selective NK1-receptor antagonist, on cisplatin-induced pica in rats. I.p. injection of cisplatin at doses of 5 and 10 mg / kg induced an increase of kaolin intake, especially significantly at 10 mg/ kg, for 2 days afterward in a dose-dependent manner (Table 1) . I.p. single administration of selective NK1-receptor antagonists, HSP-117 and CP-99,994, markedly inhibited the cisplatin-induced increase of kaolin intake both on the first day and the second day (Fig. 1A) . Recently, the potent and broad-spectrum anti-emetic activity of NK1-receptor antagonists have been demonstrated in several emetic models (5 -7), and they have been regarded as potential novel antiemetics (10) . In particular, NK1-receptor antagonists inhibited cisplatin-induced delayed emesis in ferrets (13) . In addition, HSP-117 also resulted in inhibition of cisplatin-induced delayed emesis in ferrets (data not shown), which suggested that it may act centrally via the area postrema (11, 12) . These findings suggested that inhibition of pica in rats on the second day by NK1-receptor antagonists corresponds to suppression in delayed emesis in ferrets by them. Furthermore, a single i.c.v. injection of HSP-117 was very effective, but (R)-HSP-117 had no effect (Fig. 1B) . Therefore, central NK1 receptors appear to play an important role in pica, which is induced by cisplatin in rats.
Ondansetron, a 5-HT 3-receptor antagonist, significantly inhibited the cisplatin-induced increase of kaolin intake on the first day, but not on the second day (Fig. 2) . The result here of the first day after cisplatin was consistent with that of Takeda et al. (1) , which was measured by kaolin intake on the first day alone after administration of ondansetron (1 and 2 mg/kg, i.p.). The finding that ondansetron did not affect the cisplatin-induced increase of kaolin intake on the second day provides additional new evidence for emesis research.
A combination of ondansetron (2 mg/ kg) with dexamethasone (1 mg/kg) tended to inhibit the increase of kaolin intake on the second day (Fig. 2) . The 5-HT3-receptor antagonist ondansetron has been shown to substantially improve cisplatin-induced acute emesis (14) , and the interaction between ondansetron and dexamethasone have been investi- gated with respect to delayed emesis. Rudd and Naylor reported that the co-administration of ondansetron and dexamethasone had an additive effect in abolishing cisplatin-induced delayed emesis in ferrets (15) . It is interesting because their report is consistent with clinical findings and our present results. Thus, we concluded that the cisplatin-induced increase in kaolin intake on the second day is analogous to delayed emesis in other species.
In conclusion, cisplatin-induced pica in rats was observed as evidence by the continuous increase of kaolin intake, the increase of which was not biphasic. However, the reactivity against HSP-117 and ondansetron was different with respect to the first and the second increase in kaolin intake. The present results indicate that the first increase is related to both 5-HT3 and NK1 receptors, while the second increase is related to NK1 but not to 5-HT 3 receptors. These findings suggest that cisplatin-induced continuous pica in rats represents a useful animal model of not only acute but delayed emesis. In addition, the NK 1 antagonist HSP-117 will become a novel and worthy antiemetic for acute and delayed emesis.
